{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:56:26Z","timestamp":1763765786779},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":3891,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1093\/annonc\/mdp122","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T02:33:58Z","timestamp":1242700438000},"page":"iv34-iv36","source":"Crossref","is-referenced-by-count":70,"special_numbering":"S4","title":["Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up"],"prefix":"10.1016","volume":"20","author":[{"given":"C.","family":"Jackson","sequence":"first","affiliation":[]},{"given":"D.","family":"Cunningham","sequence":"additional","affiliation":[]},{"given":"J.","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdp122_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp122_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00130404-200307000-00007","article-title":"Preoperative therapy with concurrent paclitaxel\/carboplatin\/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial","volume":"9","author":"Meluch","year":"2003","journal-title":"Cancer J"},{"key":"10.1093\/annonc\/mdp122_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp122_bb0025","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/jco.2007.25.18_suppl.4510","article-title":"Final results of a randomized trial comparing preoperative 5-fluorouracil (F)\/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial","volume":"25","author":"Boige","year":"2007","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1093\/annonc\/mdp122_bb0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"MacDonald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp122_bb0035","article-title":"Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: Update of the results of Intergroup Study INT-0116 (SWOG 9008)","author":"MacDonald","year":"2004","journal-title":"In ASCO Gastrointestinal Cancers Symposium, Edition"},{"key":"10.1093\/annonc\/mdp122_bb0040","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ejso.2008.02.002","article-title":"An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer","volume":"34","author":"Liu","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mdp122_bb0045","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp122_bb0050","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","article-title":"Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data","volume":"24","author":"Wagner","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp122_bb0055","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp122_bb0060","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/annonc\/mdn166","article-title":"Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction","volume":"19","author":"Dank","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp122_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp122_bb0070","article-title":"Randomized phase III trial of capecitabine\/cisplatin (XP) vs. continuous infusion of 5-FU\/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results","volume":"24","author":"Kang","year":"2006","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1093\/annonc\/mdp122_bb0075","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","article-title":"Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie","volume":"26","author":"Al-Batran","year":"2008","journal-title":"J Clin Oncol"},{"issue":"Suppl 8","key":"10.1093\/annonc\/mdp122_bb0080","article-title":"Meta-analysis of the REAL-2 and ML17032 trials comparing capecitabine with 5-fluorouracil (5-FU) in advanced oesophago-gastric cancer","volume":"19","author":"Okines","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1093\/annonc\/mdp122_bb0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00280-007-0516-6","article-title":"A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy","volume":"61","author":"Lee","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdp122_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdh007","article-title":"Phase II study of irinotecan and 5-fluorouracil\/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma","volume":"15","author":"Assersohn","year":"2004","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419405383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419405383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/20\/suppl_4\/iv34\/344877\/mdp122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T05:12:50Z","timestamp":1589778770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419405383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":17,"alternative-id":["S0923753419405383"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp122","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}